Cart
sales@molnova.com
BML-259
CAS No. 267654-00-2
BML-259( CAY10554 )
Catalog No. M28107 CAS No. 267654-00-2
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 163 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 477 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1014 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBML-259
-
NoteResearch use only, not for human use.
-
Brief DescriptionBML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
-
DescriptionBML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.(In Vitro):BML-259 prevents a large population of cells from NAC-evoked cell death.
-
In VitroBML-259 (10 μM) protects large population of cells against non-Aβ component of Alzheimer's disease amyloid (NAC)-evoked cell death.
-
In Vivo——
-
SynonymsCAY10554
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorAntifungal|Antiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number267654-00-2
-
Formula Weight260.36
-
Molecular FormulaC14H16N2OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (480.12 mM)
-
SMILESO=C(NC1=NC=C(S1)C(C)C)CC=2C=CC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Freitas-Silva O, et al. Tracing fungi secondary metabolites in Brazil nuts using LC-MS/MS. Drug Metab Lett. 2011 Aug;5(3):150-5.
molnova catalog
related products
-
Rosavin
Rosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.
-
CDK inhibitor E9
CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12.
-
ON-013100
ON-013100 is an antineoplastic drug. ON-013100 also acts as a mitotic inhibitor that could inhibit Cyclin D1 expression.
